search results for

refine results

sort by


result type


Press Releases

The Fed considers new policy tools

CNBC's Rick Santelli speaks to Andy Brenner, National Alliance Securities, about the Federal Reserve rate hike timing and considering new policy tools.


Jim Cramer talks influences that helped EpiPen price changes

CNBC's Jim Cramer says Monday recent price adjustments from EpiPen's owner Mylan can be partially attributed to the rise of vocal social media platforms.


Does the market owe investors more?

CNBC’s Mike Santoli takes a look at what investors can expect near these record levels, and whether or not it's still a young bull market.


Golfer Tom Watson on golf returning to the Olympics

CNBC’s Dominic Chu talks to golfing legend Tom Watson at the Gary Player Invitational Series kick off about golf returning to the Olympics and golfing for charity.


RBC: Netflix is number-one buy

RBC Capital analyst Mark Mahaney weighs in on Netflix's stock, international push and original content.


Strong dollar weighing on oil

Global Commodity Research at Bank of America Merrill Lynch Francisco Blanch weighs in on whether investors should be bearish or bullish on the oil sector.


Icahn refutes Ackman’s claim, buys more Herbalife

CNBC’s Kate Kelly on the latest with billionaire Carl Icahn upping his stake in Herbalife by more than two million shares.


EpiPen goes generic

CNBC’s Meg Tirrell reports the latest on Mylan announcing that it will offer a generic version of its life-saving allergy EpiPen for half the list price of the brand name treatment.


Firefighters battle blaze at Philadelphia church

CNBC's Sara Eisen on the latest on the two-alarm fire in Philadelphia.


FANG ends with a 'dang' (buy last year's losers): Pro

Fundstrat Global Advisors Founder Tom Lee, and UBS Senior Investment Strategist Stephen Freedman discuss the Fed, the state of the economy and earnings.